Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001231919-20-000013
Filing Date
2020-03-11
Accepted
2020-03-10 22:23:48
Documents
1
Effectiveness Date
2020-03-11
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11243
  Complete submission text file 0001231919-20-000013.txt   12436
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Filer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
Type: D | Act: 33 | File No.: 021-362487 | Film No.: 20703810
SIC: 2836 Biological Products, (No Diagnostic Substances)